@article{152a42af58df47fbbf62645beef4ef17,
title = "Passage of the comprehensive immunosuppressive drug coverage for kidney transplant patients act-a chance to celebrate and reflect",
author = "Gill, \{John S.\} and Formica, \{Richard N.\} and Barbara Murphy",
note = "Funding Information: R.N. Formica is president of the American Society of Transplantation; reports consultancy agreements with Gennentech, Malinkrodt Pharmaceuticals, and Veloxis Pharmaceuticals; other interests/relationships as president of American Society of Transplantation and as a member of the UNOS/OPTN Membership and Professional Standards Committee. J.S. Gill is president elect of the American Society of Transplantation; is supported by a Foundation Award from the Canadian Institutes of Health Research; has received research funding from Astellas; and reports being a scientific advisor or membership with the Declaration of Istanbul Custodial Group. B. Murphy is councilor of the American Society of Nephrology and past president of the American Society of Transplantation; reports consultancy agreements with RenalytixAI and Verici Dx; ownership interest in Renalytix AI and Verici Dx; research funding from NIH; honoraria from University of Virginia and Yale; patents and inventions from Verici Dx; scientific advisor or board membership of Linus, Trelus, RenalytixAI, Veloxis, and Vertex.",
year = "2021",
month = apr,
doi = "10.1681/ASN.2020121811",
language = "English",
volume = "32",
pages = "774--776",
journal = "Journal of the American Society of Nephrology",
issn = "1046-6673",
publisher = "Wolters Kluwer Health",
number = "4",
}